NKGen Biotech (NKGN) Stock Price Prediction & Forecast

On September 2, NKGen Biotech (NKGN) was assigned a Hold with a target price of $0.01. This signal was predicated on several factors, including a month-over-month drop in Instagram followers, and a month-over-month drop in Facebook fans.
The conviction in the pick is low due to the limited amount of alternative data available.

Based on Alternative Data, NKGen Biotech is a hold.

Alternative data suggests that it's recommended to approach NKGen Biotech (NKGN) with caution. While there are positive indicators, the overall assessment suggests a hold based on Alternative Data analysis. However, this information should not be considered financial advice.

With an AI score of 49, the NKGN stock forecast suggests stability.

To predict the price for NKGN in 2027, we can extrapolate the AI price target. This approach projects NKGN's price to reach $0.

To predict the price for NKGN in 2030, we can again extrapolate the AI price target. This approach projects NKGN's price to reach $0.

When predicting the price for NKGN, our approach incorporates multiple scores assessing different aspects of the company. The Brand score measures growth and engagement across social media channels, indicating audience reach. The Employee score evaluates workforce health, considering job postings, business outlook, and employee ratings. The Customer score examines engagement on websites, app downloads, and sentiment in stock forums. Lastly, the Fundamental score analyzes financial statements and analyst ratings. By evaluating this data, we gain a holistic view of the company's performance, enabling more informed price predictions.

Based on technical analysis of how the price has moved over the last 6 months is hard to tell since there has been no significant change in the price today to base a prediction on. Note that this is a simplistic analysis and should be used with caution, as prices are influenced by a myriad of factors.